Invokana (canagliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to control blood sugar in people with type 2 diabetes mellitus, in addition to diet and exercise.
| Manufacturer | Janssen |
|---|---|
| Brand Name | Invokana |
| Dosage | The recommended starting dose of canagliflozin is 100 mg once daily. In patients tolerating canagliflozin 100 mg once daily who have an estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 or CrCl ≥ 60 mL/min and need tighter glycaemic control, the dose can be increased to 300 mg once daily . OR AS PRESCRIBED |
| Dosage Form | TABLET |
| Size | 30 |
| Active Ingredients | Canagliflozin |
| Side Effects | N/A |
| Contraindications | N/A |
Write Your Own Review